Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562/Dox cells to doxorubicin
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562/Dox cells to doxorubicin
Authors
Keywords
Metformin, 2-Deoxyglucose, Multidrug resistance, P-glycoprotein, Energy metabolism
Journal
TUMOR BIOLOGY
Volume 37, Issue 7, Pages 8587-8597
Publisher
Springer Nature
Online
2016-01-06
DOI
10.1007/s13277-015-4478-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin in Cancer Treatment and Prevention
- (2015) Daniel R. Morales et al. Annual Review of Medicine
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- Metformin and the risk of endometrial cancer: A population-based cohort study
- (2015) Emily M. Ko et al. GYNECOLOGIC ONCOLOGY
- Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo
- (2015) SHINTARO FUJIHARA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
- (2015) Renata Silva et al. PHARMACOLOGY & THERAPEUTICS
- The effect of mitochondrial ATP-sensitive potassium channels on apoptosis of chick embryo cecal cells by Eimeria tenella
- (2015) Sha-sha Yang et al. RESEARCH IN VETERINARY SCIENCE
- Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway
- (2015) Zaid H. Maayah et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
- (2015) Hossam M. Abdallah et al. Journal of Advanced Research
- Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression
- (2014) Shu-Ching Hsieh et al. AMINO ACIDS
- Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway
- (2014) Ting Chen et al. CANCER BIOLOGY & THERAPY
- Sweat but no gain: Inhibiting proliferation of multidrug resistant cancer cells with “ersatzdroges”
- (2014) Yoonseok Kam et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanisms of P-Glycoprotein Alteration During Anticancer Treatment: Role in the Pharmacokinetic and Pharmacological Effects of Various Substrate Drugs
- (2014) Takuro Kobori et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner
- (2014) Ming-Ju Tsai et al. LUNG CANCER
- Protective Effects of Calycosin Against CCl4-Induced Liver Injury with Activation of FXR and STAT3 in Mice
- (2014) Xinli Chen et al. PHARMACEUTICAL RESEARCH
- Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells
- (2014) Ming Ming et al. PLoS One
- Role of integrated cancer nanomedicine in overcoming drug resistance
- (2013) Arun K. Iyer et al. ADVANCED DRUG DELIVERY REVIEWS
- Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?
- (2013) Vivian M. Rumjanek et al. BIOSCIENCE REPORTS
- Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin
- (2013) Xiaokui Huo et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Inhibitory Effect of Valsartan on the Intestinal Absorption and Renal Excretion of Bestatin in Rats
- (2013) Xiaokui Huo et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways
- (2013) Minh Truong Do et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Autophagy Regulation and Integration with Cell Signaling
- (2011) Anne Hamacher-Brady ANTIOXIDANTS & REDOX SIGNALING
- Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin
- (2010) Sarah J. Hemauer et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
- (2010) M Gerlinger et al. BRITISH JOURNAL OF CANCER
- Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation
- (2010) Hyung Gyun Kim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
- (2010) I. Ben Sahra et al. CANCER RESEARCH
- Molecular Mechanisms of Biliary Excretion of Cefditoren and the Effects of Cefditoren on the Expression Levels of Hepatic Transporters
- (2010) Qiang Meng et al. Drug Metabolism and Pharmacokinetics
- Is it Time to Test Metformin in Breast Cancer Clinical Trials?
- (2009) M. Cazzaniga et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started